Vascular Erectile Dysfunction and Subclinical Cardiovascular Disease

Current Sexual Health Reports
Zain GowaniMichael J Blaha

Abstract

We review the recent literature on the hypothesized temporal relationship between subclinical cardiovascular disease (CVD), vascular erectile dysfunction (ED), and clinical CVD. In addition, we combine emerging research with expert consensus guidelines such as The Princeton Consensus III to provide a preventive cardiologist's perspective toward an ideal approach to evaluating and managing CVD and ED risk in patients. Development of ED was found to occur during the progression from subclinical CVD to clinical CVD. A strong association was observed between subclinical CVD as assessed by coronary artery calcium (CAC) and carotid plaque and subsequent ED, providing evidence for the role of subclinical CVD in predicting ED. ED is also identified as a substantial independent risk factor for overt clinical CVD, and ED symptoms may precede CVD symptoms by 2-3 years. Given the body of evidence on the relationship between subclinical CVD, ED, and clinical CVD we recommend that all men with vascular ED should undergo cardiovascular risk assessment. We further recommend using CAC scores for advanced risk assessment in patients at low-intermediate to intermediate risk (5-20% CVD risk), with risk driving subsequent lifestyle and pharmacologi...Continue Reading

References

Apr 20, 2004·Journal of the American College of Cardiology·Maple M FungElizabeth Barrett-Connor
Jan 26, 2005·Circulation·Amir Lerman, Andreas M Zeiher
Oct 18, 2005·Journal of the American College of Cardiology·Emilio ChiurliaMaria G Modena
Jan 18, 2006·JAMA : the Journal of the American Medical Association·Ian M ThompsonCharles A Coltman
Mar 28, 2008·The New England Journal of Medicine·Robert DetranoRichard A Kronmal
Nov 6, 2008·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·John H LeeJames H O'Keefe
Feb 3, 2009·Mayo Clinic Proceedings·Brant A InmanSteven J Jacobsen
Jun 30, 2010·International Journal of Clinical Practice·G JacksonM Miner
Dec 8, 2010·Cardiology in Review·David ShinJulius M Gardin
Jun 28, 2011·The Journal of Sexual Medicine·Katherine García-MalpartidaAntonio Hernández-Mijares
Jan 10, 2013·Circulation. Cardiovascular Quality and Outcomes·Charalambos V VlachopoulosChristodoulos I Stefanadis
Jan 26, 2013·The Journal of Sexual Medicine·Jatinder KumarPravin K Goel
Sep 10, 2013·European Urology·Giorgio GandagliaCharalambos Vlachopoulos
Jan 16, 2014·The American Journal of Medicine·Martin MinerFrederick Wu
Mar 19, 2014·The Journal of Sexual Medicine·Yuanshan CuiYong Zhang
Apr 2, 2014·The Journal of Sexual Medicine·John B Kostis, Jeanne M Dobrzynski
Dec 3, 2014·JACC. Cardiovascular Imaging·Ashleigh O GibsonJoseph Yeboah
Oct 16, 2016·Global Heart·Michael J BlahaPhilip Greenland

❮ Previous
Next ❯

Citations

Jan 29, 2020·Pharmacology & Therapeutics·Emma MitidieriRaffaella Sorrentino
Aug 31, 2021·European Heart Journal·Frank L J VisserenUNKNOWN ESC Scientific Document Group
Feb 25, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lei ChenGuang-Jiang Shi
Sep 25, 2021·European Journal of Preventive Cardiology·Frank L J VisserenUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.